|
INTS4L2 expression based on
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.915820E-02 |
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.982300E-02 |
| Normal-vs-Stage2 |
2.277600E-01 |
| Normal-vs-Stage3 |
3.850400E-02 |
| Normal-vs-Stage4 |
1.168600E-01 |
| Stage1-vs-Stage2 |
5.188200E-01 |
| Stage1-vs-Stage3 |
9.527200E-01 |
| Stage1-vs-Stage4 |
9.641800E-01 |
| Stage2-vs-Stage3 |
5.344200E-01 |
| Stage2-vs-Stage4 |
6.290600E-01 |
| Stage3-vs-Stage4 |
9.939600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.250000E-02 |
| Normal-vs-AfricanAmerican |
5.073200E-01 |
| Normal-vs-Asian |
1.968030E-01 |
| Caucasian-vs-AfricanAmerican |
7.816400E-03 |
| Caucasian-vs-Asian |
7.955000E-01 |
| AfricanAmerican-vs-Asian |
9.319900E-02 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.400500E-02 |
| Normal-vs-Female |
4.749800E-02 |
| Male-vs-Female |
8.988400E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.118560E-01 |
| Normal-vs-Age(41-60Yrs) |
1.878090E-02 |
| Normal-vs-Age(61-80Yrs) |
4.808200E-02 |
| Normal-vs-Age(81-100Yrs) |
7.695500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.523600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.139000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.096600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.072400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.938000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.887200E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.021400E-01 |
| Classical-VS-Follicular |
1.994420E-02 |
| Classical-VS-Other |
7.230200E-01 |
| Classical-VS-Normal |
9.184100E-02 |
| Tall-VS-Follicular |
4.424600E-01 |
| Tall-VS-Other |
9.917800E-01 |
| Tall-VS-Normal |
1.223020E-01 |
| Follicular-VS-Other |
6.887400E-01 |
| Follicular-VS-Normal |
4.064500E-03 |
| Other-VS-Normal |
3.975600E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.104200E-03 |
| Normal-vs-N1 |
4.318700E-03 |
| N0-vs-N1 |
2.909800E-01 |
|
|
